Hong Kong stocks opened, the Hang Seng Index rose 1.28%, the index rose 2.06%. WuXi AppTec (02359.HK) rose 7.5%, Q3 net profit rose 53.27%.
港股开盘,恒指开涨1.28%,科指开涨2.06%。药明康德(02359.HK)开涨7.5%,Q3净利润大涨53.27%。
Hong Kong stocks opened, the Hang Seng Index fell 0.8%, the Hang Seng Technology Index fell 0.97%; Zijin Mining (02899.HK) opened today, lower 1.6%; WuXi Bio (02269.HK) opened down 2.95%, WuXi PharmaTech (02359.HK) opened down 2.07%.
Hong Kong stocks closed, the Hang Seng Index closed down 0.43%, the index closed down 0.24%, the pharmaceutical sector collectively weakened, WuXi PharmaTech (02359.HK) closed down 5.65%.
港股收盘,恒指收跌0.43%,科指收跌0.24%,医药板块集体走弱,药明康德(02359.HK)收跌5.65%。
Hong Kong stocks of innovative drug concept stocks fell collectively, Zaiding Pharmaceutical (09688.HK) fell more than 11%, Hengrui Pharmaceutical (01276.HK), Goree Pharmaceutical (01672.HK), Genting Xinyao (01952.HK) fell more than 5%, WuXi AppTec (02359.HK) fell more than 4%, Cinda Biological (01801.HK), WuXi Ming United (02268.HK), Hansen Pharmaceutical (03692.HK) fell more than 3%.
港股创新药概念股集体下跌,再鼎医药(09688.HK)跌超11%,恒瑞医药(01276.HK)、歌礼制药(01672.HK)、云顶新耀(01952.HK)跌超5%,药明康德(02359.HK)跌超4%,信达生物(01801.HK)、药明合联(02268.HK)、翰森制药(03692.HK)跌超3%。
Hong Kong biomedical stocks rebounded sharply, Rongchang Bio (09995.HK) rose more than 9.5%, WuXi Bio (02269.HK) rose more than 7.5%, WuXi PharmaTech (02268.HK) rose more than 6%, WuXi PharmaTech (02359.HK), Junshi Biosciences (01877.HK) rose more than 5%, Konoya (02162.HK), Fuhong Hanlin (02696.HK) and so on.